Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ravi Salgia

Showing results (61-70 of 528) with videos related to

Pageof 53
Sort By:
Cancer Letters|June 1, 2005
c-Met as a target for human cancer and characterization of inhibitors for therapeutic interventionJames G Christensen, Jon Burrows, Ravi Salgia
The Oncologist|November 7, 2009
The role of EGFR inhibition in the treatment of non-small cell lung cancerMandira Ray, Ravi Salgia, Everett E Vokes
Biochimica Et Biophysica Acta. Reviews on Cancer|March 20, 2026
mRNA-based cancer vaccines: A new frontier in personalized immunotherapyPankaj Garg, Ravi Salgia, Sharad S Singhal
Biochemical Pharmacology|March 10, 2026
Epitranscriptomic signatures of malignancy: how RNA modifications shape breast and ovarian tumor progressionPankaj Garg, Ravi Salgia, Sharad S Singhal
Biochimica Et Biophysica Acta. Reviews on Cancer|January 26, 2018
EphB4: A promising target for upper aerodigestive malignanciesRavi Salgia, Prakash Kulkarni, Prakash S Gill
Seminars in Oncology|February 26, 2004
Targeted molecules in small cell lung cancerNevin Murray, Ravi Salgia, Frank V Fossella
Cancer Treatment and Research|May 29, 2004
Therapeutic targeting of the receptor tyrosine kinase MetMartin Sattler, Patrick C Ma, Ravi Salgia
Journal of Biomolecular Structure & Dynamics|June 20, 2022
Intrinsic disorder, extraterrestrial peptides, and prebiotic life on the earthPrakash Kulkarni, Ravi Salgia, Vladimir N Uversky
Nature Clinical Practice. Oncology|January 30, 2007
Lung carcinoma in African AmericansOyewale Abidoye, Mark K Ferguson, Ravi Salgia
Tumori|June 11, 2013
Etoposide and temozolomide in combination for the treatment of progressive small-cell lung cancer central nervous system metastases: two casesRimas V Lukas, Janani Vigneswaran, Ravi Salgia
Pageof 53

Showing results (61-70 of 528) with videos related to

Sort By:
Pageof 53
Cancer Letters|June 1, 2005
c-Met as a target for human cancer and characterization of inhibitors for therapeutic interventionJames G Christensen, Jon Burrows, Ravi Salgia
The Oncologist|November 7, 2009
The role of EGFR inhibition in the treatment of non-small cell lung cancerMandira Ray, Ravi Salgia, Everett E Vokes
Biochimica Et Biophysica Acta. Reviews on Cancer|March 20, 2026
mRNA-based cancer vaccines: A new frontier in personalized immunotherapyPankaj Garg, Ravi Salgia, Sharad S Singhal
Biochemical Pharmacology|March 10, 2026
Epitranscriptomic signatures of malignancy: how RNA modifications shape breast and ovarian tumor progressionPankaj Garg, Ravi Salgia, Sharad S Singhal
Biochimica Et Biophysica Acta. Reviews on Cancer|January 26, 2018
EphB4: A promising target for upper aerodigestive malignanciesRavi Salgia, Prakash Kulkarni, Prakash S Gill
Seminars in Oncology|February 26, 2004
Targeted molecules in small cell lung cancerNevin Murray, Ravi Salgia, Frank V Fossella
Cancer Treatment and Research|May 29, 2004
Therapeutic targeting of the receptor tyrosine kinase MetMartin Sattler, Patrick C Ma, Ravi Salgia
Journal of Biomolecular Structure & Dynamics|June 20, 2022
Intrinsic disorder, extraterrestrial peptides, and prebiotic life on the earthPrakash Kulkarni, Ravi Salgia, Vladimir N Uversky
Nature Clinical Practice. Oncology|January 30, 2007
Lung carcinoma in African AmericansOyewale Abidoye, Mark K Ferguson, Ravi Salgia
Tumori|June 11, 2013
Etoposide and temozolomide in combination for the treatment of progressive small-cell lung cancer central nervous system metastases: two casesRimas V Lukas, Janani Vigneswaran, Ravi Salgia
Pageof 53